Recent Updates
Recently added Catalysts
FULC Neutral Sentiment

Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on Tuesday, February 27, 2024, at 8:00 a.m. ET

Tuesday, February 20, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Fulcrum Therapeutics, Inc. announced it will release its fourth quarter and full year 2023 financial results on February 27, 2024, before U.S. markets open. A conference call and webcast is scheduled for 8:00 a.m. ET on the same day to discuss the results and provide updates on corporate developments. Participants can register for the call to receive dial-in details, and an archive of the webcast will be available afterward.
Price reaction · baseline $9.64 (2024-02-16 close) · hit after-hours · clean, no other FULC news in the window
day 0 close · peak
-1.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Fulcrum Therapeutics is proactively providing financial results and updates.
  • The company focuses on developing treatments for genetically defined rare diseases.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
15.6%
average across 6 past catalysts
Cash runway
~59 mo
Minimal dilution risk
Lead asset
Pociredir
Phase 2 · Sickle Cell Disease

Full Press Release Details

CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its fourth quarter and full year 2023 financial results will be released on Tuesday, February 27, 2024 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.
Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and unique PIN which will allow them to access the call. An audio webcast will be accessible through the Investor Relations section of the company’s website at www.fulcrumtx.com or by clicking here. Following the live webcast, an archived replay will also be available.
About Fulcrum Therapeutics

Frequently Asked Questions

When will Fulcrum Therapeutics release its financial results?

Fulcrum Therapeutics will release its financial results on February 27, 2024.

What time is the conference call on February 27, 2024?

The conference call is scheduled for 8:00 a.m. ET.

Where can I access the audio webcast?

The audio webcast can be accessed on Fulcrum's Investor Relations website.

How can individuals register for the conference call?

Individuals can register for the conference call through the provided link.

Will there be a replay available after the live webcast?

Yes, an archived replay of the webcast will be available after the live event.

ShareAdd on Google
Tags: FULC Viatris Investor Conferences Healthcare Fulcrum Therapeutics 2023 financial results conference call biopharmaceutical company
Last updated: Feb 20, 2024

Biotech snapshot

Cash runway
$319M liquidity · $5M/mo burn
~59 mo
Minimal dilution risk
Lead asset
PociredirPhase 2
Sickle Cell Disease →

Catalyst track record

+32%
best trade around FULC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for FULC.

See every catalyst's timing & PoA →